These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 39205152)

  • 21. Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients.
    Konuma T; Hamatani-Asakura M; Nagai E; Adachi E; Kato S; Isobe M; Monna-Oiwa M; Takahashi S; Yotsuyanagi H; Nannya Y
    Int J Hematol; 2024 Aug; 120(2):229-240. PubMed ID: 38842630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients.
    Bajpai D; Bose S; Saxena N; Kulkarni B; Kumar K; Rao N; Thakare S; Torane V; Nataraj G; Jamale T
    Vaccine; 2024 Nov; 42(25):126206. PubMed ID: 39122634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection.
    Byrne J; Gu L; Garcia-Leon A; Gaillard CM; Saini G; Alalwan D; Tomás-Cortázar J; Kenny G; Donohue S; Reynolds B; O'Gorman T; Landay A; Doran P; Stemler J; Koehler P; Cox RJ; Olesen OF; Lelievre JD; O'Broin C; Savinelli S; Feeney ER; O'Halloran JA; Cotter A; Horgan M; Kelly C; Sadlier C; de Barra E; Cornely OA; Gautier V; Mallon PW
    Front Immunol; 2024; 15():1445653. PubMed ID: 39355249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study.
    Muñoz-Gómez MJ; Ryan P; Quero-Delgado M; Martin-Vicente M; Cuevas G; Valencia J; Jiménez E; Blanca-López N; Lara-Álvarez MÁ; Hernández-Rivas JÁ; Redondo G; Mas V; Sepúlveda-Crespo D; Vázquez M; Torres-Macho J; Martínez I; Resino S
    J Infect Public Health; 2024 Jul; 17(7):102473. PubMed ID: 38865774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination.
    Page L; Dennehy K; Mueller K; Girl P; Loell E; Buijze H; Classen JM; Messmann H; Roemmele C; Hoffmann R; Wurster S; Fuchs A
    Front Immunol; 2024; 15():1423766. PubMed ID: 39267758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.
    Alter G; Yu J; Liu J; Chandrashekar A; Borducchi EN; Tostanoski LH; McMahan K; Jacob-Dolan C; Martinez DR; Chang A; Anioke T; Lifton M; Nkolola J; Stephenson KE; Atyeo C; Shin S; Fields P; Kaplan I; Robins H; Amanat F; Krammer F; Baric RS; Le Gars M; Sadoff J; de Groot AM; Heerwegh D; Struyf F; Douoguih M; van Hoof J; Schuitemaker H; Barouch DH
    Nature; 2021 Aug; 596(7871):268-272. PubMed ID: 34107529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longevity of hybrid immunity against SARS-CoV-2 in adults vaccinated with an adenovirus-based COVID-19 vaccine.
    Mvula M; Mtonga F; Mandolo J; Jowati C; Kalirani A; Chigamba P; Lisimba E; Mitole N; Chibwana MG; Jambo KC
    BMC Infect Dis; 2024 Sep; 24(1):959. PubMed ID: 39266969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
    Cheng Y-L; Chang S-S; Chao C-H; Chen P-T; Lin Y-L; Syu G-D; Lee N-Y; Chen P-L; Ko W-C; Ho T-S
    Microbiol Spectr; 2024 Jun; 12(6):e0000424. PubMed ID: 38747636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination.
    Younes S; Nicolai E; Pieri M; Bernardini S; Daas HI; Al-Sadeq DW; Younes N; Shurrab FM; Nizamuddin PB; Humaira F; Al-Dewik N; Yassine HM; Abu-Raddad LJ; Ismail A; Nasrallah GK
    Influenza Other Respir Viruses; 2024 May; 18(5):e13290. PubMed ID: 38706402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
    Tarke A; Coelho CH; Zhang Z; Dan JM; Yu ED; Methot N; Bloom NI; Goodwin B; Phillips E; Mallal S; Sidney J; Filaci G; Weiskopf D; da Silva Antunes R; Crotty S; Grifoni A; Sette A
    Cell; 2022 Mar; 185(5):847-859.e11. PubMed ID: 35139340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
    Hill JA; Martens MJ; Young JH; Bhavsar K; Kou J; Chen M; Lee LW; Baluch A; Dhodapkar MV; Nakamura R; Peyton K; Howard DS; Ibrahim U; Shahid Z; Armistead P; Westervelt P; McCarty J; McGuirk J; Hamadani M; DeWolf S; Hosszu K; Sharon E; Spahn A; Toor AA; Waldvogel S; Greenberger LM; Auletta JJ; Horowitz MM; Riches ML; Perales MA
    Clin Infect Dis; 2024 Aug; 79(2):542-554. PubMed ID: 38801746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
    Wang Z; Muecksch F; Schaefer-Babajew D; Finkin S; Viant C; Gaebler C; Hoffmann HH; Barnes CO; Cipolla M; Ramos V; Oliveira TY; Cho A; Schmidt F; Da Silva J; Bednarski E; Aguado L; Yee J; Daga M; Turroja M; Millard KG; Jankovic M; Gazumyan A; Zhao Z; Rice CM; Bieniasz PD; Caskey M; Hatziioannou T; Nussenzweig MC
    Nature; 2021 Jul; 595(7867):426-431. PubMed ID: 34126625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.
    Holder KA; Ings DP; Fifield KE; Barnes DA; Barnable KA; Harnum DOA; Russell RS; Grant MD
    J Immunol; 2024 Oct; 213(8):1105-1114. PubMed ID: 39248629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.
    Zhang S; Xu K; Li C; Zhou L; Kong X; Peng J; Zhu F; Bao C; Jin H; Gao Q; Zhao X; Zhu L
    Front Immunol; 2022; 13():829665. PubMed ID: 35154152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
    Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.
    Lv Z; Li Q; Feng Z; Zheng X; NaYin ; Yang H; Gu Q; Ying S; Qi Y; Li X; Wu R; Wu Z; Yu X; Zou N; Qin D; Wan C
    Int Immunopharmacol; 2022 Jan; 102():108383. PubMed ID: 34824035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.
    Guo L; Zhang Q; Gu X; Ren L; Huang T; Li Y; Zhang H; Liu Y; Zhong J; Wang X; Chen L; Zhang Y; Li D; Fang M; Xu L; Li H; Wang Z; Li H; Bai T; Liu W; Peng Y; Dong T; Cao B; Wang J
    Lancet Microbe; 2024 Jan; 5(1):e24-e33. PubMed ID: 38048805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 reinfection broadens the antibody responses and promotes the phenotypic differentiation of virus-specific memory T cells in adolescents.
    Zhao XJ; Liu XL; Gu HJ; Liu T; Li DY; Zhang S; Wu J; Du KG; Tian S; Chen JJ; Xu Q; Lv CL; Jiang BG; Wang H; Kou ZQ; Wang GL; Fang LQ
    J Med Virol; 2024 Aug; 96(8):e29873. PubMed ID: 39165041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sputnik V-Induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela.
    Franco C; Cornejo A; Rodríguez M; García A; Belisario I; Mayora S; Garzaro DJ; Jaspe RC; Hidalgo M; Parra N; Liprandi F; Zambrano JL; Rangel HR; Pujol FH
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.
    Liu J; Chandrashekar A; Sellers D; Barrett J; Jacob-Dolan C; Lifton M; McMahan K; Sciacca M; VanWyk H; Wu C; Yu J; Collier AY; Barouch DH
    Nature; 2022 Mar; 603(7901):493-496. PubMed ID: 35102312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.